Early extensive viremia, but not rs8099917 genotype, is the only predictor for cholestatic hepatitis C after living‐donor liver transplantation. Issue 6 (12th November 2012)
- Record Type:
- Journal Article
- Title:
- Early extensive viremia, but not rs8099917 genotype, is the only predictor for cholestatic hepatitis C after living‐donor liver transplantation. Issue 6 (12th November 2012)
- Main Title:
- Early extensive viremia, but not rs8099917 genotype, is the only predictor for cholestatic hepatitis C after living‐donor liver transplantation
- Authors:
- Ikegami, Toru
Shirabe, Ken
Fukuhara, Takasuke
Furusyo, Norihiro
Kotoh, Kazuhiro
Kato, Masaki
Shimoda, Shinji
Aishima, Shinichi
Soejima, Yuji
Yoshizumi, Tomoharu
Maehara, Yoshihiko - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hepr12003-sec-0001" sec-type="section"> <title>Aim</title> <p>Cholestatic hepatitis C is one of the most serious but still unaddressed disorders after liver transplantation.</p> </sec> <sec id="hepr12003-sec-9001" sec-type="section"> <title>Methods</title> <p>In this study, we analyzed 49 patients who underwent living‐donor liver transplantation (LDLT) to treat hepatitis C virus (HCV) infection.</p> </sec> <sec id="hepr12003-sec-0002" sec-type="section"> <title>Results</title> <p>Five patients developed cholestatic hepatitis C, with total bilirubin of 15.2 ± 3.1 mg/dL at diagnosis 6.2 ± 1.0 weeks after LDLT. Univariate analysis showed that larger graft to standard liver volume ratio, higher HCV RNA titer at 2 weeks, earlier peak HCV RNA titer and cytomegalovirus infection were the significant risk factors. The development of cholestatic hepatitis C was not significantly associated with interleukin‐28B genotype (rs8099917); four out of five affected patients had the T/T genotype. Multivariate analysis showed that higher HCV RNA titer at 2 weeks was the only significant factor (<italic>P</italic> = 0.026) for the development of cholestatic hepatitis C. Receiver–operator curve analysis showed that that HCV RNA titer of more than 7.2 log<sub>10</sub>IU/mL was the optimal cut‐off for characterizing cholestatic hepatitis C. All of the patients were serum HCV RNA negative after treatment<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hepr12003-sec-0001" sec-type="section"> <title>Aim</title> <p>Cholestatic hepatitis C is one of the most serious but still unaddressed disorders after liver transplantation.</p> </sec> <sec id="hepr12003-sec-9001" sec-type="section"> <title>Methods</title> <p>In this study, we analyzed 49 patients who underwent living‐donor liver transplantation (LDLT) to treat hepatitis C virus (HCV) infection.</p> </sec> <sec id="hepr12003-sec-0002" sec-type="section"> <title>Results</title> <p>Five patients developed cholestatic hepatitis C, with total bilirubin of 15.2 ± 3.1 mg/dL at diagnosis 6.2 ± 1.0 weeks after LDLT. Univariate analysis showed that larger graft to standard liver volume ratio, higher HCV RNA titer at 2 weeks, earlier peak HCV RNA titer and cytomegalovirus infection were the significant risk factors. The development of cholestatic hepatitis C was not significantly associated with interleukin‐28B genotype (rs8099917); four out of five affected patients had the T/T genotype. Multivariate analysis showed that higher HCV RNA titer at 2 weeks was the only significant factor (<italic>P</italic> = 0.026) for the development of cholestatic hepatitis C. Receiver–operator curve analysis showed that that HCV RNA titer of more than 7.2 log<sub>10</sub>IU/mL was the optimal cut‐off for characterizing cholestatic hepatitis C. All of the patients were serum HCV RNA negative after treatment with pegylated interferon and ribavirin and all the patients are alive.</p> </sec> <sec id="hepr12003-sec-0003" sec-type="section"> <title>Conclusion</title> <p>Early extensive viremia, but not the rs8099917 genotype, was the only predictor for cholestatic hepatitis C after LDLT.</p> </sec> </abstract> … (more)
- Is Part Of:
- Hepatology research. Volume 43:Issue 6(2013:Jun.)
- Journal:
- Hepatology research
- Issue:
- Volume 43:Issue 6(2013:Jun.)
- Issue Display:
- Volume 43, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 43
- Issue:
- 6
- Issue Sort Value:
- 2013-0043-0006-0000
- Page Start:
- 621
- Page End:
- 629
- Publication Date:
- 2012-11-12
- Subjects:
- Liver -- Diseases -- Periodicals
Liver Diseases -- Periodicals
Foie -- Maladies -- Périodiques
616.362 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09284346 ↗
http://firstsearch.oclc.org/journal=1386-6346;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1872-034X ↗
http://www.sciencedirect.com/science/journal/13866346 ↗
http://www3.interscience.wiley.com/journal/118507311/home ↗
http://www.blackwell-synergy.com/rd.asp?goto=journal&code=hep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hepr.12003 ↗
- Languages:
- English
- ISSNs:
- 1386-6346
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.845000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3360.xml